- Home
- PYPD vs NCRA Comparison
PYPD vs NCRA Comparison
Compare PYPD & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- NCRA
- Stock Information
- Founded
- PYPD 2008
- NCRA 2002
- Country
- PYPD Israel
- NCRA Taiwan
- Employees
- PYPD N/A
- NCRA N/A
- Industry
- PYPD Medical/Dental Instruments
- NCRA Farming/Seeds/Milling
- Sector
- PYPD Health Care
- NCRA Consumer Staples
- Exchange
- PYPD Nasdaq
- NCRA Nasdaq
- Market Cap
- PYPD 16.5M
- NCRA 12.6M
- IPO Year
- PYPD 2020
- NCRA N/A
- Fundamental
- Price
- PYPD $3.22
- NCRA $0.82
- Analyst Decision
- PYPD Strong Buy
- NCRA
- Analyst Count
- PYPD 2
- NCRA 0
- Target Price
- PYPD $12.00
- NCRA N/A
- AVG Volume (30 Days)
- PYPD 29.2K
- NCRA 8.4K
- Earning Date
- PYPD 02-12-2025
- NCRA 08-14-2024
- Dividend Yield
- PYPD N/A
- NCRA N/A
- EPS Growth
- PYPD N/A
- NCRA N/A
- EPS
- PYPD N/A
- NCRA N/A
- Revenue
- PYPD N/A
- NCRA $20,483,694.00
- Revenue This Year
- PYPD N/A
- NCRA N/A
- Revenue Next Year
- PYPD N/A
- NCRA N/A
- P/E Ratio
- PYPD N/A
- NCRA N/A
- Revenue Growth
- PYPD N/A
- NCRA N/A
- 52 Week Low
- PYPD $2.37
- NCRA $0.70
- 52 Week High
- PYPD $9.20
- NCRA $1.54
- Technical
- Relative Strength Index (RSI)
- PYPD 53.21
- NCRA 41.47
- Support Level
- PYPD $2.37
- NCRA $0.76
- Resistance Level
- PYPD $3.13
- NCRA $1.14
- Average True Range (ATR)
- PYPD 0.32
- NCRA 0.11
- MACD
- PYPD 0.05
- NCRA -0.01
- Stochastic Oscillator
- PYPD 64.89
- NCRA 35.82
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.